KR20030061127A - The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide - Google Patents
The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide Download PDFInfo
- Publication number
- KR20030061127A KR20030061127A KR1020020001513A KR20020001513A KR20030061127A KR 20030061127 A KR20030061127 A KR 20030061127A KR 1020020001513 A KR1020020001513 A KR 1020020001513A KR 20020001513 A KR20020001513 A KR 20020001513A KR 20030061127 A KR20030061127 A KR 20030061127A
- Authority
- KR
- South Korea
- Prior art keywords
- chitosan
- chitooligosaccharide
- hypertension
- kimchi
- chitooligosaccharides
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 22
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 18
- 235000013305 food Nutrition 0.000 title claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 title description 4
- 230000003014 reinforcing effect Effects 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 claims abstract description 115
- 235000021109 kimchi Nutrition 0.000 claims abstract description 40
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 28
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108010089807 chitosanase Proteins 0.000 claims abstract description 11
- 239000000539 dimer Substances 0.000 claims description 39
- 239000013638 trimer Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 230000006196 deacetylation Effects 0.000 claims description 6
- 238000003381 deacetylation reaction Methods 0.000 claims description 6
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 13
- 238000011282 treatment Methods 0.000 abstract description 12
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 150000003839 salts Chemical class 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract description 2
- 235000011293 Brassica napus Nutrition 0.000 abstract 1
- 240000008100 Brassica rapa Species 0.000 abstract 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 description 13
- 238000002156 mixing Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 241000220259 Raphanus Species 0.000 description 7
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 5
- 230000005070 ripening Effects 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000003276 anti-hypertensive effect Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000007862 Capsicum baccatum Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000001728 capsicum frutescens Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 2
- 108010064733 Angiotensins Proteins 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/10—Preserving with acids; Acid fermentation
- A23B7/105—Leaf vegetables, e.g. sauerkraut
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/20—Products from fruits or vegetables; Preparation or treatment thereof by pickling, e.g. sauerkraut or pickles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01132—Chitosanase (3.2.1.132)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 고혈압 억제능이 강화된 키토올리고당의 제조방법과 상기 키토올리고당을 함유한 식품, 보다 상세하게는 김치, 동치미에 관한 것이다.The present invention relates to a method for producing chitooligosaccharide enhanced hypertension and food containing the chitooligosaccharide, more specifically kimchi, Dongchimi.
일반적으로, 키토올리고당(Chitosan Oligo Saccharide)은 수용액에 쉽게 용해되지 않고 체내 흡수율이 낮은 고분자물질인 키토산을 산 혹은 효소로 분해하여인체 흡수가 잘 되도록 만든 것이다.In general, chitosan oligo sugar (Chitosan Oligo Saccharide) is not easily dissolved in an aqueous solution, but the high absorption of the body in the chitosan, which is a high molecular material with low absorption rate in the body is made to absorb the human body.
또한 키토올리고당은 키토산의 구조를 가지면서 글루코사민 6탄당(단당류)이 2개에서 12개 정도로 결합되어 있는 당을 말한다.In addition, chitooligosaccharide refers to a sugar having a structure of chitosan and glucosamine hexavalent sugar (monosaccharide) is bound to two to twelve.
또한 키토올리고당은 콜레스테롤 저하작용, 종양억제작용, 면역재생작용, 항균작용, 정장작용을 하는 등 생리활성기능이 높다.In addition, chitooligosaccharide has a high physiological activity such as cholesterol lowering effect, tumor suppression effect, immune regeneration effect, antibacterial effect, and intestinal action.
상기와 같은 키토올리고당은 캅셀, 농축액의 형태로 개발되고 있으며, 키토올리고당 이외에 토코페롤, 비타민, 영양효모 등을 함께 첨가하여 가공식품 형태로 개발하고 있다.Such chitooligosaccharides are being developed in the form of capsules and concentrates, and in addition to chitooligosaccharides, tocopherols, vitamins, nutritional yeasts, etc., have been developed in the form of processed foods.
상기 키토올리고당 가공식품은 건강보조식품의 주요 식품군으로 키토올리고당의 체내 중금속 제거, 항암작용, 항균작용 및 노화예방 등 다양한 효능이 부각됐기 때문이다.The chitooligosaccharide processed food is the main food group of health supplements because of the various effects such as the removal of heavy metals in the body, anti-cancer, antibacterial action and aging of chitooligosaccharides.
그러나 상기와 같은 키토올리고당에 관한 연구들은 고차 올리고당에 해당되며 2량체 또는 3량체 올리고당을 함유한 키토올리고당에 관한 연구는 부진한 편이다.However, such studies on chitooligosaccharides correspond to higher oligosaccharides and studies on chitooligosaccharides containing dimers or trimer oligosaccharides are poor.
또한 본 발명과 관련하여 고혈압은 모든 성인병, 특히 순환기 계통의 근원적인 원인이 되는 만성 퇴행성 질환인데 가장 흔하고도 관리가 잘 안되는 성인병으로 생활이 도시화, 공업화, 복잡화되고 평균수명이 연장되어 인구가 노령화되어 갈수록 고혈압의 빈도와 분포 즉, 유병률은 더욱 높아지고 있다.In addition, hypertension is a chronic degenerative disease that causes all adult diseases, especially the circulatory system, and is the most common and poorly managed adult disease. As a result, urbanization, industrialization, complicated life expectancy, and extended life expectancy lead to aging population. Increasingly, the frequency and distribution of hypertension, or prevalence, is increasing.
이에 본 발명자들은 2량체와 3량체의 올리고당이 증가된 키토올리고당이 고혈압 발병원인인 안지오텐신 전환효소를 억제함을 확인하여, 고혈압 억제능이 강화된 키토올리고당의 생산방법을 제공하고자 한다.Accordingly, the present inventors have confirmed that chitooligosaccharides having increased oligosaccharides of dimers and trimers inhibit angiotensin converting enzymes, which are the cause of hypertension, and provide a method for producing chitooligosaccharides having enhanced hypertension inhibitory ability.
또한 본 발명자들은 상기 생산된 키토올리고당을 김치 또는 동치미에 첨가하여 고혈압 억제능이 강화된 김치 또는 동치미를 제공하고자 한다.In addition, the present inventors add the produced chitooligosaccharide to kimchi or Dongchimi to provide kimchi or Dongchimi with enhanced hypertension inhibitory ability.
도 1은 2량체와 3량체의 올리고당 함량이 증가된 키토올리고당의 제조공정도이다.1 is a manufacturing process diagram of the chitooligosaccharides with increased oligosaccharide content of dimers and trimers.
도 2는 2량체와 3량체의 올리고당 함량이 증가된 키토올리고당을 함유한 김치의 제조공정도이다.Figure 2 is a manufacturing process of kimchi containing chitooligosaccharides with increased oligosaccharide content of dimers and trimers.
도 3은 2량체와 3량체의 올리고당 함량이 증가된 키토올리고당을 함유한 동치미의 제조공정도이다.Figure 3 is a manufacturing process of the Dongchimi containing chitooligosaccharides with increased oligosaccharide content of dimers and trimers.
본 발명은 고혈압 억제능이 강화된 키토올리고당의 제조방법과 상기 키토올리고당을 함유한 식품, 보다 상세하게는 김치, 동치미에 관한 것이다.The present invention relates to a method for producing chitooligosaccharide enhanced hypertension and food containing the chitooligosaccharide, more specifically kimchi, Dongchimi.
본 발명은 탈아세틸화도가 90%이상, 점도가 10cps∼40cps의 범위를 갖는 키토산을 2.0%∼6.0% 되도록 초산 1.0%∼4.0% 용액에 용해시키고 pH4.5∼pH6.0, 온도 30℃∼40℃, 키토사나제 1.5∼3.5unit/g 키토산의 조건에서 15시간 이상 반응시켜 2량체와 3량체의 증가된 키토올리고당을 생산하는 방법을 특징으로 한다.In the present invention, chitosan having a deacetylation degree of 90% or more and a viscosity in the range of 10 cps to 40 cps is dissolved in a 1.0% to 4.0% solution of acetic acid so as to be 2.0% to 6.0%. A method of producing dimers and trimers of increased chitooligosaccharides by reaction at 40 ° C. and chitosanase at 1.5 to 3.5 units / g chitosan for at least 15 hours.
또한 본 발명은 상기 키토올리고당을 함유한 김치 또는 동치미를 특징으로 한다.In another aspect, the present invention is characterized by kimchi or Dongchimi containing the chitooligosaccharide.
이하에서는 본 발명의 구성을 보다 구체적으로 실시예, 실험예 또는 비교예 및 도면이나 도표에 의거하여 보다 상세히 설명하기로 하겠다. 다만, 본 발명의 권리범위는 실시예나 도면에 의하여 본 발명의 청구범위가 한정되는 것은 아니다.Hereinafter, the configuration of the present invention will be described in more detail based on Examples, Experimental Examples or Comparative Examples and drawings or diagrams. However, the scope of the present invention is not limited to the claims of the present invention by the embodiments or the drawings.
실시예1.Example 1
2량체와 3량체의 올리고당이 증가된 키토올리고당의 제조Preparation of Chitooligosaccharides with Increased Dimers and Trimers of Oligosaccharides
탈아세틸화도가 90%이상이고 점도가 10cps∼40cps 범위의 키토산을 2%∼6% 되도록 초산 1%∼4% 용액에 첨가하고 30℃∼40℃에서 3시간 가용시켰다. 상기 가용화된 용액에 키토사나제를 키토산 g당 1.5∼3.5unit를 첨가하여 15시간∼30시간 반응시켰다. 상기 키토사나제를 첨가한 키토산을 70℃에서 30분간 가열하여 키토사나제를 실활시켜서 2량체 및 3량체의 올리고당 함량이 증가된 키토올리고당을 생산하였다. 또한 상기 2량체 및 3량체의 올리고당이 증가된 키토올리고당의 제조공정을 도1에 나타내었다.Chitosan having a deacetylation degree of 90% or more and a viscosity ranging from 10 cps to 40 cps was added to a 1% to 4% solution of acetic acid and allowed to be used at 30 ° C to 40 ° C for 3 hours. Chitosanase was added to the solubilized solution at 1.5 to 3.5 units per g of chitosan and reacted for 15 to 30 hours. Chitosan to which chitosanase was added was heated at 70 ° C. for 30 minutes to inactivate chitosanase, thereby producing chitooligosaccharides with increased oligosaccharide content of dimers and trimers. In addition, the manufacturing process of the chitooligosaccharide with the oligosaccharide of the dimer and trimer is shown in FIG.
실험예1Experimental Example 1
키토올리고당에 함유된 2량체와 3량체 올리고당의 시간에 따른 변화량The amount of dimer and trimer oligosaccharides in chitooligosaccharides over time
상기 실시예1에 의해 생산된 점도 10cps, 17cps, 20cps, 40cps를 갖는 각각의 키토산을 원료로 생산된 2량체 및 3량체의 올리고당이 증가된 네가지 키토올리고당의 당량체를 15시간, 30시간 마다 TSK gel amide-80 칼럼을 이용한 HPLC 장치(system)로 분석하여 2량체와 3량체의 올리고당의 함량을 측정 분석하였다.TSK produced by the chitosan having a viscosity of 10 cps, 17 cps, 20 cps, and 40 cps produced by Example 1 with the dimers and trimers of the oligosaccharides of four oligosaccharides increased by 15 hours, every 30 hours. The oligosaccharide content of dimer and trimer was measured and analyzed by HPLC system using gel amide-80 column.
그 결과 키토산을 15시간 분해할 경우, 2량체 및 3량체의 올리고당 함량은 각각 9.1%∼10.3%와 11.8%∼18.3%인데 반해 상기 키토산을 30시간 분해할 경우, 각각 10.4%∼11.3%와 22.6%∼23.2%로 높게 나타났으며 이러한 결과로 상기 2량체 및3량체의 올리고당 함량과 키토산의 점도는 큰 관계가 없고, 시간에 비례함을 확인하였다.As a result, the oligosaccharide content of dimers and trimers is 9.1% to 10.3% and 11.8% to 18.3%, respectively, when chitosan is decomposed for 15 hours, whereas 10.4% to 11.3% and 22.6 are decomposed for 30 hours to decompose chitosan, respectively. As a result, it was confirmed that the oligosaccharide content of the dimers and trimers and the viscosity of chitosan were not significantly related and were proportional to time.
또한, 상기 탈아세틸화도가 90%이상의 키토산을 재료물질로 사용함은 키토산은 탈아세틸과정에서 아미노기를 갖게 됨으로서 산에 쉽게 용해되는 가용성을 갖게 되므로 키토산은 탈아세틸화도(Deacetylation)에 따라 키토산의 효능이 결정되기 때문이다.In addition, the use of chitosan having a deacetylation degree of 90% or more as a material material indicates that chitosan has an amino group in the deacetylation process, so that it is easily soluble in acid, and thus chitosan has an effect of chitosan according to the degree of deacetylation. Because it is determined.
실험예2Experimental Example 2
키토사나제반응온도에 따른 2량체 및 3량체의 올리고당이 증가된 키토올리고당 생성 Production of chitooligosaccharides with increased oligosaccharides of dimers and trimers according to chitosanase reaction temperature
상기 실시예1에 의해 생산된 20cps 점도를 갖는 키토산을 원료로 제조된 2량체 및 3량체의 키토올리고당의 키토사나제를 실활시키고 생성된 올리고당의 함량을 TSK gel amide-80 칼럼을 이용한 HPLC 장치(system)로 측정 분석하였다.HPLC apparatus using a TSK gel amide-80 column was inactivated chitosanase of dimers and trimers of chitooligosaccharides prepared from chitosan having a 20 cps viscosity produced by Example 1 as a raw material system).
그 결과 2량체 및 3량체 함량은 20시간 반응하였을 때 최대생성량을 나타내었고, 30℃에서 35.25%, 35℃에서 40%, 40℃에서 42.75%의 결과로 반응온도에 비례하여 2량체 및 3량체 생성량이 증가함을 확인하였다.As a result, the dimer and trimer content showed the maximum yield when reacted for 20 hours, resulting in 35.25% at 30 ° C, 40% at 35 ° C, and 42.75% at 40 ° C. It was confirmed that the production amount increased.
실험예3Experimental Example 3
키토올리고당의 ACE 억제효과 및 2량체와 3량체 함량ACE Inhibitory Effect and Dimer and Trimer Contents of Chitooligosaccharides
상기 실시예1에 의해 생산된 20cps 점도를 갖는 키토산을 원료로 제조된 2량체 및 3량체의 키토올리고당의 2량체와 3량체 함량을 TSK gel amide-80 칼럼을 이용한 HPLC 장치(system)로 측정 분석하였다. 또한 상기 2량체 및 3량체의 올리고당을 함유한 키토올리고당의 제조공정을 도1에 나타내었다. 또한 쿠쉬만(Cushman)과 챙(Cheung)의 방법을 이용하여 ACE 억제 효과를 측정하였다. 즉 0.1M 소오디움 보레이트 완충용액(sodium borate buffer)에 ACE 0.004unit와 키토올리고당을 첨가하고, 여기에 기질로서 히푸릴 히스티딘-루이신(Hippuryl His-Leu)용액 50㎕를 가하여 37℃ 10분간 반응시킨 다음 0.2N 염산(HCl)이 되도록 하여 반응을 정지시켰다. 여기에 에틸아세테이트(ethyl acetate)3㎖를 가하고 상층액 2.5㎖를 취하여 건조시키며 증류수 3㎖에 용해시킨 후 228㎚에서 흡광도를 측정하여 아래의 식에 따라 ACE 저해 활성을 계산하였다.The dimer and trimer content of dimers and trimers of chitooligosaccharides prepared as raw materials of chitosan having a 20 cps viscosity produced by Example 1 was measured and analyzed by HPLC system using TSK gel amide-80 column. It was. In addition, the manufacturing process of the chitooligosaccharide containing the oligomer of the dimer and trimer is shown in FIG. In addition, the effects of ACE inhibition were measured using the method of Cushman and Cheung. In other words, ACE 0.004 unit and chitooligosaccharide were added to 0.1M sodium borate buffer, and 50 μl of Hypuryl Histidine-Leucine solution as a substrate was added thereto, followed by reaction at 37 ° C. for 10 minutes. The reaction was stopped by adding 0.2N hydrochloric acid (HCl). 3 ml of ethyl acetate was added thereto, 2.5 ml of the supernatant was taken, dried, dissolved in 3 ml of distilled water, and absorbance was measured at 228 nm. ACE inhibition activity was calculated according to the following formula.
ACE 저해활성(inhibitory activity:%)=(1-A/B)×100ACE inhibitory activity (%) = (1-A / B) × 100
A : 시료첨가구의 흡광도A: Absorbance of Sample Addition
B : 시료무첨가구의 흡광도B: Absorbance of Sample-Free Furniture
그 결과 20시간 반응했을 때 2량체와 3량체의 함량은 42.75%로 최대를 나타내었으며 이 때의 ACE 억제효과는 45.35%로 처리구 중 가장 높게 나타났다. 또한 상기의 결과에서 2량체와 3량체의 함량은 반응시간이 20시간일 때 2량체와 3량체의 함량이 최대로 생성되어 ACE 억제효과가 최대로 나타났으며, 2량체와 3량체의 함량이 증가할수록 ACE 억제효과가 증가하는 것으로 나타나 2량체와 3량체의 올리고당이 증가된 키토올리고당이 ACE를 억제함을 확인하였다. 이는 홍등(Chitosan 올리고당의 안지오텐신 전환효소 활성억제 및 SHR에서의 고혈압 억제특성, 홍상필외, 한국식품과학회지(30)6, 1998)이 키토올리고당의 아미노기(C2-NH2group)가 시험조건인 pH8.3에서 친핵성(nucleophile)을 나타내기 때문에 아연(zinc)이온과 결합할 수 있고, C말단의 양이온을 가지는 활성부위와 이온결합이 일어날 수 있으며 키토올리고당의 수산기(-OH group) 혹은 아미노기(C2-NH2group)가 중앙의 H+활성부위와 수소결합을 이룰 수 있다는 것과 입체적인 효소-기질 반응의 적합성에 의하여 키토올리고당 중 3량체의 키토올리고당이 가장 높은 ACE 저해활성을 나타내고 있을 가능성이 높다고 보고한 것을 고려할 때 키토올리고당은 김치 및 동치미의 ACE 활성 억제에 매우 효과적인 물질인 것으로 판단된다.As a result, when the reaction was 20 hours, the dimer and trimer content was 42.75%, the maximum, and the ACE inhibitory effect was 45.35%, the highest among the treatments. In the above results, the content of dimer and trimer was the maximum content of dimer and trimer when the reaction time was 20 hours, resulting in the maximum ACE inhibitory effect, and the content of dimer and trimer Increasing ACE inhibitory effect was found to increase the oligosaccharides of dimers and trimers of the oligosaccharides were confirmed to inhibit the ACE. The red light (inhibition of angiotensin converting enzyme activity of chitosan oligosaccharide and hypertension inhibition in SHR, Sang-pil Hong et al., Korean Journal of Food Science and Technology (30) 6, 1998) showed that the amino group of chitooligosaccharide (C 2 -NH 2 group) was tested. Because it shows nucleophile at pH8.3, it can bind with zinc ions, ionic bonds with active sites containing c-terminal cations, and hydroxyl groups (-OH group) or amino groups of chitooligosaccharides. The possibility that the (C 2 -NH 2 group) could form hydrogen bonds with the central H + active site and the conformation of three-dimensional enzyme-substrate reactions could possibly result in the highest ACE inhibitory activity of the chitooligosaccharides of the chitooligosaccharides. Considering this high report, chitooligosaccharide is considered to be a very effective substance for inhibiting ACE activity of Kimchi and Dongchimi.
실시예2Example 2
키토올리고당을 함유한 김치제조Kimchi production containing chitooligosaccharide
상기 실시예1에 의해 생산된 20cps 점도를 갖는 키토산을 원료로 제조된 2량체 및 3량체의 키토올리고당을 사용하여 이하의 표4와 같은 배합비로 다양한 김치를 제조하였다. 도2에 따라 주재료(배추)를 정선하고 절단하여 주재료 중량의 0.2%∼0.3% 소금을 살포하며 15℃에서 3시간∼4시간 염지하였다. 상기 염지 후에 세척하고 탈수하여 양념재료와 키토올리고당을 혼합하여 버무르기하여 김치를 제조하였다. 상기 김치를 일정 용기에 담아 10℃에서 산도가 0.6% 수준이 될 때까지 발효숙성시켰다.Chitosan having a viscosity of 20 cps produced by Example 1 was prepared using various dimers and trimers of chitooligosaccharides as raw materials, and various kimchis were prepared at the compounding ratios shown in Table 4 below. The main material (cabbage) was selected and cut as shown in FIG. After the dyeing, washing and dehydration to mix kimchi oligosaccharides with seasoning material to mix to prepare kimchi. The kimchi was placed in a container and fermented at 10 ° C. until the acidity reached 0.6%.
비교예1Comparative Example 1
배합비별로 제조된 김치의 관능검사Sensory Evaluation of Kimchi Prepared by Mixing Ratio
상기 실시예2에 의해 배합비별로 제조된 숙성된 김치를 패널 30인을 대상으로 외관, 향미, 질감(아삭거림), 색, 전체적기호도 등에 대한 관능검사를 5점 평가법으로 실시하여 평균으로 표5에 나타내었다.Sensory tests on the appearance, flavor, texture (crunching), color, overall symbolism, etc. of 30 aged kimchi prepared by blending ratio according to Example 2 were carried out by a five-point evaluation method. Indicated.
상기 표4에 의한 배합비별로 제조한 김치의 외관항목과 향미 항목에서 전체적으로 4.2점∼4.5점으로 비교적 높은 평가점수를 보였다. 김치의 질감(아삭거림) 항목에서 패널들은 차이를 보였고 색 항목에서는 처리구 중 고춧가루를 가장 많이 첨가한 C처리구가 4.7점으로 가장 높았고 종합적 기호도에 있어서도 C처리구가 4.6점으로 가장 높게 나타났다.The kimchi produced by the blending ratio according to Table 4 showed relatively high evaluation scores, from 4.2 to 4.5, in terms of appearance and flavor. In the kimchi texture (crunching) category, the panels showed a difference, and in the color category, the C treatment group that added the most red pepper powder was the highest with 4.7 points and the C treatment group with the highest degree of overall preference at 4.6 points.
비교예2Comparative Example 2
키토올리고당을 첨가한 김치와 키토올리고당을 첨가하지 않은 김치의 적숙기에서 ACE억제효과, pH, 산도 비교Comparison of ACE Inhibitory Effect, pH, and Acidity in the Ripening Period of Kimchi with Chitooligosaccharide and Kimchi without Chitooligosaccharide
상기 실시예2의 배합비 중 처리구C를 사용하여 김치를 제조한 것을 실험군으로 하고 처리구C의 배합비 중 키토올리고당을 제외하여 제조한 김치를 대조군으로 하였다. 또한 본 비교예에 사용된 대조군과 실험군 외에 다른 김치의 ACE, pH 및 산도를 측정하기 위해서 시중에 판매되고 있는 상품김치를 4개 선별하여 같은 방법으로 측정하였다. 대조군, 실험군, 상품김치1, 2, 3, 4를 적숙기에서 시료를 채취하고 처리구별 김치의 ACE, pH 및 산도를 측정하여 표6에 나타내었다.Kimchi prepared using Treatment C in the blending ratio of Example 2 was used as an experimental group, and kimchi prepared by excluding chitooligosaccharide in the blending ratio of Treatment C was used as a control. In addition, in order to measure the ACE, pH and acidity of other kimchi in addition to the control group and the experimental group used in this comparative example, four commercially available kimchi was selected and measured by the same method. The control, experimental group, commodity kimchi 1, 2, 3, 4 were sampled in the ripening period and the ACE, pH and acidity of kimchi by treatment groups were measured and shown in Table 6.
그 결과 ACE 억제효과를 보면 대조군의 ACE억제활성은 45.49%로 나타난 반면 키토올리고당을 첨가한 실험군은 71.75%로 현저히 ACE 억제활성을 나타내었다.As a result, the ACE inhibitory effect of the control group was 45.49%, whereas the chitooligosaccharide-added experimental group was 71.75%.
또한 산도는 대조군에 비해 실험군은 감소하였는데 이것은 키토산을 1%∼4%의 초산용액에 용해시켜 키토올리고당을 제조한 것으로 사료되었다.In addition, the acidity was decreased in the experimental group compared to the control group, which was considered to be the preparation of chitooligosaccharide by dissolving chitosan in 1% ~ 4% acetic acid solution.
비교예3Comparative Example 3
키토올리고당을 함유한 김치의 고혈압 억제효과Antihypertensive Effects of Kimchi Containing Chitooligosaccharides
실험에 사용된 쥐는 생후 8주령된 웅성 SHR/NCrj(Charles River Japan Inc.)를 공급받아서 실험에 공시하기 전 혈압측정용 홀더에 1주일간 적응훈련을 실시한 다음 1주일간 기준혈압(Reference Blood Pressure)을 측정하였다. 실험에 사용한 SHR의 주령은 약 10주령으로서 수축기혈압이 180㎜Hg∼200㎜Hg을 나타내는 것으로 6마리를 선별하였다.The mice used in the experiment were supplied with male SHR / NCrj (Charles River Japan Inc.), 8 weeks old, and subjected to a week of adaptive training on the blood pressure measuring holder prior to the test. Measured. The SHR used for the experiment was about 10 weeks old, and 6 animals were selected as systolic blood pressure showing 180 mmHg to 200 mmHg.
상기의 실시예2의 배합비중 처리구C를 사용하여 김치를 제조하고 적숙기 수준으로 발효숙성시켜 제조한 김치의 국물을 상기 선발된 6마리의 SHR에 음용수로서 하루 3번 2주간 급여하면서 수축기혈압에 미치는 변화를 측정하여 표7에 나타내었다.The kimchi broth prepared by fermentation ripening at the maturity level was prepared using the blending weight treatment C of Example 2, and the systolic blood pressure was fed to the selected six SHRs as drinking water three times a day for two weeks. The change is measured and shown in Table 7.
그 결과 전체적으로 실험군은 대조군에 비해 감소하는 경향을 보였다. 시험전 평균기준혈압(Reference Blood Pressure)은 192.8±15.3㎜Hg으로서 음용수 급여 후 14일경에는 대조군은 195.0㎜Hg로 초기 기준혈압에 비해 큰 변화가 없었으나 실험군은 184.6㎜Hg로 시간이 경과함에 따라 초기혈압에서 유의하게 감소하는 경향을 나타내어 2량체와 3량체 올리고당을 함유한 키토올리고당이 혈압을 저하시키는 것을 확인하였다.As a result, the experimental group as a whole showed a tendency to decrease compared to the control group. The reference blood pressure before the test was 192.8 ± 15.3mmHg. At 14 days after drinking water, the control group had 195.0mmHg, which was not significantly changed compared to the initial reference blood pressure. It showed a tendency to decrease significantly in the initial blood pressure, and it was confirmed that chitooligosaccharides containing dimers and trimer oligosaccharides lowered blood pressure.
실시예3Example 3
키토올리고당을 함유한 동치미제조Manufacture of Dongchimi Containing Chitooligosaccharide
상기 실시예1에 의해 생산된 20cps 점도를 갖는 키토산을 원료로 제조된 2량체 및 3량체의 키토올리고당을 사용하여 이하의 표8과 같은 배합비로 다양한 동치미를 제조하였다. 도3에 따라 주재료(무우)를 정선하고 세척하여 항아리 바닥에 소금을 깔고 통째로 무우를 넣고 2일 동안 염지하였다. 염지한 무우를 돌로 누르고, 양념재료를 정선 및 절단하여 만든 배주머니를 무우의 중앙에 끼워 두었다. 상기 무와 양념재료에 소금과 물의 비율이 1:18이고 키토올리고당을 함유한 소금물을 부어서 10℃에서 산도가 0.6% 수준이 될 때까지 발효 숙성시켰다.Chitosan having a viscosity of 20 cps produced by Example 1 was prepared using various dimers and trimers of chitooligosaccharides prepared as raw materials at various mixing ratios as shown in Table 8 below. The main material (beet) was selected and washed according to Figure 3, and the salt was placed on the bottom of the jar, and the whole radish was put and soaked for 2 days. The dried radish was pressed with stone, and a bag made by selecting and cutting seasoning materials was placed in the center of the radish. The ratio of salt and water in the radish and seasoning material is 1:18, and brine containing chitooligosaccharide was poured and fermented and aged until the acidity was 0.6% at 10 ° C.
비교예1Comparative Example 1
배합비별로 제조된 동치미의 관능검사Sensory Evaluation of Dongchimi Prepared by Mixing Ratio
상기 실시예3에 의해 배합비별로 제조된 숙성된 동치미를 패널 30인을 대상으로 외관, 향미, 질감(아삭거림), 새콤한 맛, 종합적기호도 등에 대한 5점 평가법으로 관능평가를 행하였으며, 그 결과를 평균적으로 표9에 나타내었다.Sensory evaluation was carried out by the five-point evaluation method for the appearance, flavor, texture (crunching), sour taste, general taste, etc. of 30 aged panels of aged Dongchimi prepared by blending ratio according to Example 3, and the result In average, it is shown in Table 9.
상기 방법으로 제조한 동치미의 외관과 향미는 전체적으로 4.1∼4.7점으로 비교적 높은 평가를 보였으며 풋고추와 홍고추 그리고 배의 비율이 외관항목과 향미항목에 큰 영향을 미친 것으로 추측되었다. 높은 염도의 소금물에서 장시간 침지시켜 제조하여 무우의 사각사각한 정도가 줄어들어 아삭거림항목이나 기호도항목이낮게 평가되었으며, 다른 부재료보다 첨가되는 배의 양이 동치미의 새콤하고 상큼한 맛에 영향을 주는 것으로 평가되었으며, 종합적으로 볼 때 A처리구 동치미가 전체적 기호도가 가장 높게 평가되었다.The appearance and flavor of Dongchimi prepared by the above method were relatively high, with a score of 4.1 to 4.7, and the ratios of green pepper, red pepper and pear had a great influence on the appearance and flavor. It is produced by immersing in salt water of high salinity for a long time, and the crunchy items and palatability items are lowered because the degree of crunchyness of radishes is decreased. Overall, Dongchimi A had the highest overall acceptability.
비교예2Comparative Example 2
키토올리고당을 함유한 동치미와 키토올리고당을 함유하지 않은 동치미의 적숙기에서 ACE억제효과, pH, 산도ACE inhibitory effect, pH, and acidity in the maturation period of Dongchimi containing chitooligosaccharide and Dongchimi not containing chitooligosaccharide
상기의 실시예3의 배합비 중 처리구A를 사용하여 키토올리고당을 제외한 동치미인 대조군을 제조하고, 키토올리고당을 함유한 동치미인 실험군을 제조하여 적숙기에 대조군과 실험군 각각를 채취하고 처리구별 동치미의 ACE, pH 및 산도를 측정하여 표10에 나타내었다.In the mixing ratio of Example 3, the treatment group A was used to prepare a control group, which was the same as Chichiol, except for the chitooligosaccharides. pH and acidity were measured and shown in Table 10.
그 결과 ACE 억제효과를 보면 대조군의 활성은 39.98%로 나타난 반면 키토올리고당을 첨가한 처리군은 70.64%로 현저히 ACE 억제활성을 나타내었다.As a result, the activity of the control group was 39.98%, while the chitooligosaccharide-treated group was 70.64%.
또한 산도는 대조군에 비해 실험군이 감소하였는데 이것은 키토산을 1%∼4%의 초산용액에 용해시켜 키토올리고당을 제조한 것으로 사료되었다.In addition, the acidity was decreased in the experimental group compared to the control group, which was considered to be the preparation of chitooligosaccharide by dissolving chitosan in 1% ~ 4% acetic acid solution.
비교예3Comparative Example 3
키토올리고당을 함유한 동치미의 고혈압 억제효과Antihypertensive Effects of Dongchimi Containing Chitooligosaccharides
실험에 사용된 쥐는 생후 8주령된 웅성 SHR/NCrj(Charles River Japan Inc.)를 공급받아서 실험에 공시하기 전 혈압측정용 홀더에 1주일간 적응훈련을 실시한 다음 1주일간 기준혈압(Reference Blood Pressure)을 측정하였다. 실험에 사용한 SHR의 주령은 약 10주령으로서 수축기혈압이 180㎜Hg∼200㎜Hg을 나타내는 것으로 6마리를 선별하였다.The mice used in the experiment were supplied with male SHR / NCrj (Charles River Japan Inc.), 8 weeks old, and subjected to a week of adaptive training on the blood pressure measuring holder prior to the test. Measured. The SHR used for the experiment was about 10 weeks old, and 6 animals were selected as systolic blood pressure showing 180 mmHg to 200 mmHg.
상기의 실시예3의 배합비 중 처리구A를 사용하여 키토올리고당을 첨가하지 않은 동치미를 제조하고, 키토올리고당을 첨가한 동치미를 제조하여 적숙기 수준으로 발효 숙성시켜 선발된 6마리의 SHR에게 동치미국물을 음용수로서 1일 3회 2주간 급여하면서 수축기혈압에 미치는 변화를 측정하여 표11에 나타내었다.Dongchimi without chitooligosaccharide was prepared using Process A of the compounding ratio of Example 3, and Dongchimi with chitooligosaccharide was added, fermented and matured to a maturity level, and the equivalent Americans were selected from six SHRs. Table 11 shows the changes in systolic blood pressure while drinking three times a day for two weeks as drinking water.
그 결과 실험군은 대조군에 비해 혈압 감소효과를 나타내었다. 시험전 평균기준혈압(reference BP)은 192.8±15.3㎜Hg으로서 음용수 급여 후 14일경에 대조군의 혈압은 190.2㎜Hg로 초기 기준혈압에 비해 큰 변화가 없었으나 실험군은 180.0㎜Hg으로 초기혈압에 비해 12㎜Hg정도 혈압이 감소하여 2량체와 3량체의 함량이 증가한 키토올리고당이 혈압억제에 유효함을 나타내었다.As a result, the experimental group showed a blood pressure reducing effect compared to the control group. The reference BP before the test was 192.8 ± 15.3mmHg, and the blood pressure of the control group was 190.2mmHg at 14 days after drinking water, but there was no significant change compared to the initial reference blood pressure. It was shown that chitooligosaccharides with dimer and trimer content increased by 12mmHg, which is effective for blood pressure control.
본 발명은 상술한 특정의 실시예, 도표나 도면에 기재된 내용에 기술적 사상이 한정되지 아니하며, 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변형의 실시가 가능한 것은 물론이고, 그와 같은 변경은 청구범위 기재의 범위 내에 있게 된다.The present invention is not limited to the technical spirit described in the specific embodiments, diagrams or drawings described above, and those skilled in the art without departing from the gist of the invention claimed in the claims. As long as anyone can carry out various modifications, such changes are within the scope of the claims.
이상에서 상세히 설명한 바와 같이, 본 발명은 2량체와 3량체 올리고당을 증가시키는 키토올리고당의 제조방법과 상기 키토올리고당을 함유한 김치 및 동치미에 관한 것이다.As described in detail above, the present invention relates to a method for preparing chitooligosaccharides to increase dimers and trimer oligosaccharides, and to kimchi and Dongchimi containing the chitooligosaccharides.
본 발명은 2량체와 3량체 올리고당 함량이 증가된 키토올리고당을 제조함으로써 고혈압을 유발시키는 안지오텐신 전환효소을 억제하여 고혈압을 억제하는 효과가 있다.The present invention has the effect of inhibiting hypertension by inhibiting angiotensin converting enzymes that cause hypertension by preparing chitooligosaccharides with increased dimer and trimer oligosaccharide contents.
또한 본 발명은 상기 키토올리고당을 첨가하여 생산한 키토올리고당을 함유한 김치 또는 동치미는 혈압을 저하시켜 고혈압을 예방 및 치료할 수 있고, 종래의 전통식품에 머물러 있던 김치와 동치미를 기능성 식품으로 발전시킬 수 있다.In addition, the present invention is a kimchi or Dongchimi containing the chitooligosaccharide produced by the addition of the chitooligosaccharide can lower blood pressure to prevent and treat hypertension, can develop kimchi and Dongchimi stayed in traditional foods as a functional food have.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020001513A KR20030061127A (en) | 2002-01-10 | 2002-01-10 | The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020001513A KR20030061127A (en) | 2002-01-10 | 2002-01-10 | The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030061127A true KR20030061127A (en) | 2003-07-18 |
Family
ID=32217616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020001513A KR20030061127A (en) | 2002-01-10 | 2002-01-10 | The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030061127A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6398395A (en) * | 1986-10-16 | 1988-04-28 | Katakura Chitsukarin Kk | Production of chitosan oligosaccharide |
KR19980034824A (en) * | 1996-11-08 | 1998-08-05 | 김세권 | Preparation method of chitosan oligosaccharide in an ultrafiltration membrane reactor using enzyme |
KR20000036774A (en) * | 2000-03-28 | 2000-07-05 | 조훈형 | Preparing Methode for Aqueous Chitosan |
KR20010017049A (en) * | 1999-08-06 | 2001-03-05 | 조정래 | Process for Preparing water-soluble chitosan oligosaccharide having low molecular weight |
KR20010103067A (en) * | 2001-08-08 | 2001-11-23 | 도영수 | Healthy instant food containing fat bonding water soluble chitosan organic acid salt |
KR20020046675A (en) * | 2000-12-15 | 2002-06-21 | 조 정 래 | Process for Producing Chitooligosaccharide by Chitosanase that Secreted from Bacillus sp HSB-21 |
-
2002
- 2002-01-10 KR KR1020020001513A patent/KR20030061127A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6398395A (en) * | 1986-10-16 | 1988-04-28 | Katakura Chitsukarin Kk | Production of chitosan oligosaccharide |
KR19980034824A (en) * | 1996-11-08 | 1998-08-05 | 김세권 | Preparation method of chitosan oligosaccharide in an ultrafiltration membrane reactor using enzyme |
KR20010017049A (en) * | 1999-08-06 | 2001-03-05 | 조정래 | Process for Preparing water-soluble chitosan oligosaccharide having low molecular weight |
KR20000036774A (en) * | 2000-03-28 | 2000-07-05 | 조훈형 | Preparing Methode for Aqueous Chitosan |
KR20020046675A (en) * | 2000-12-15 | 2002-06-21 | 조 정 래 | Process for Producing Chitooligosaccharide by Chitosanase that Secreted from Bacillus sp HSB-21 |
KR20010103067A (en) * | 2001-08-08 | 2001-11-23 | 도영수 | Healthy instant food containing fat bonding water soluble chitosan organic acid salt |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101057688A (en) | Shaddock whole fruit beverage and its producing method | |
EP0867125B1 (en) | Preservatives and method for preservation against decay | |
JP4582059B2 (en) | Anti-browning agent | |
US20060051316A1 (en) | Remedy | |
JPWO2005095427A1 (en) | Composition for prevention or treatment of thrombosis | |
EP0925719A1 (en) | Method for inhibiting trimethylamine formation and its uses | |
JP2007008899A (en) | Vascularization inhibitor | |
KR101021241B1 (en) | The method of preparing soy souce-powder treated by browned-reaction condition of ex lellence | |
US20090054373A1 (en) | Chitin derivatives for hyperlipidemia | |
KR100822305B1 (en) | Manufacturing process of seasoning liquid for pomegranate radish-wrapped and seasoning liquid and pomegranate radish-wrapped thereby | |
JP4276500B2 (en) | Method for producing saccharide composition containing N-acetylglucosamine and method for producing food and drink using the method | |
KR20030061127A (en) | The production method of chitosan oligo saccharide which is reinforcing inhibitory hypertension and thereof food containing above chitosan oligo saccharide | |
KR20010044329A (en) | Preparation method of fermented liquid base and functional foods | |
KR20010007764A (en) | The homogeneous liquid of chitosan in Japanese apricot juice | |
EP3979821B1 (en) | Composition for maintaining or improving the quality of processed meat | |
JP2008079536A (en) | Fermented soy milk and method for producing the same | |
US7335766B2 (en) | Method for producing a chitosan containing salt having a function of lowering blood pressure | |
KR20030087468A (en) | Manufacturing method of health salt included chito oligosaccharides and the salt by the method | |
KR20170022796A (en) | Kimchi seasoning stuff using the mixing extracts of Inonotus obliquus, Phellinus linteus and Sparassis crispa and the functional Kimchi using them | |
JP3944116B2 (en) | Iron odor control agent | |
CN108552445A (en) | A kind of Rocket ram jet health products beverage and preparation method thereof | |
KR20000049643A (en) | Functional fermented Seafood's Seasionings | |
KR19980020653A (en) | Manufacturing method of health supplement food containing calcium hydroxide as main ingredient | |
KR101822135B1 (en) | Method for preparing seasoning composition for bulgogi and seasoning composition for bulgogi prepared by the same | |
KR20040018889A (en) | The vinegar composition comprising chitin oligomer powder for improving liver activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |